Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.biopha.2020.110404 http://scihub22266oqcxt.onion/10.1016/j.biopha.2020.110404 32603888!7320263!32603888     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32603888&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Biomed+Pharmacother 2020 ; 129 (ä): 110404 Nephropedia Template TP {{tp|p=32603888|t=2020. Clinical implications of nicotine as an antimicrobial agent and immune modulator |pdf=|usr=}}{{32603888}} gab.com Text Clinical implications of nicotine as an antimicrobial agent and immune modulator JO: Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32603888 #FOAvip Nicotine is perhaps the most important and potent, pharmacologically active substance in tobacco products. This commentary examines the possible effects that nicotine has on microbial viability and also on the host's immune system as it responds to the indigenous microflora (the microbiome) due to nicotine-induced changes to the indigenous microbial environment and any associated antigenic stimulation / immunization that may occur. To our knowledge, the analysis of such profound microbiologic changes attributable to a tobacco-related product, such as nicotine, has not been fully explored in the context of its consequences on the viability of the microbiome/microbiota and on some of the host's basic physiologic processes, such as the immune response, and its possible association on the induction and persistence of certain immunologically related diseases. Future studies should be aimed at uncovering the molecular mechanisms involved in such interactions, especially in the context of manipulating them for therapeutic purposes. Twit Text FOAVip Clinical implications of nicotine as an antimicrobial agent and immune modulator ????Biomed Pharmacother http://www.kidney.de/pget.php?&tw=1&pmid=32603888 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32603888 #FOAvip English Wikipedia <ref>{{Cite pmid|32603888}}</ref> Clinical implications of nicotine as an antimicrobial agent and immune modulator #MMPMID32603888 Pavia CS; Plummer MM Biomed Pharmacother 2020[Sep]; 129 (ä): 110404 PMID32603888show ga Nicotine is perhaps the most important and potent, pharmacologically active substance in tobacco products. This commentary examines the possible effects that nicotine has on microbial viability and also on the host's immune system as it responds to the indigenous microflora (the microbiome) due to nicotine-induced changes to the indigenous microbial environment and any associated antigenic stimulation / immunization that may occur. To our knowledge, the analysis of such profound microbiologic changes attributable to a tobacco-related product, such as nicotine, has not been fully explored in the context of its consequences on the viability of the microbiome/microbiota and on some of the host's basic physiologic processes, such as the immune response, and its possible association on the induction and persistence of certain immunologically related diseases. Future studies should be aimed at uncovering the molecular mechanisms involved in such interactions, especially in the context of manipulating them for therapeutic purposes. |Animals[MESH] |Anti-Infective Agents/adverse effects/*therapeutic use[MESH] |Dysbiosis[MESH] |Host-Pathogen Interactions[MESH] |Humans[MESH] |Immune System/*drug effects/immunology[MESH] |Immunologic Factors/adverse effects/*therapeutic use[MESH] |Microbiota/*drug effects[MESH] |Nicotine/adverse effects/*therapeutic use[MESH]Clinical implications of nicotine as an antimicrobial agent and immune(epmc).pdf DeepDyve Pubget Overpricing